7.25
0.00
(0.00%)
At close: 2:52:25 PM GMT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,367.65
3,367.65
3,008.30
2,024.00
1,409.00
Cost of Revenue
2,229.86
2,229.86
2,229.11
1,525.00
945.00
Gross Profit
1,137.79
1,137.79
779.19
499.00
464.00
Operating Expense
3,786.61
3,786.61
3,467.49
1,865.00
1,622.00
Operating Income
-2,648.82
-2,648.82
-2,688.30
-1,366.00
-1,158.00
Net Non Operating Interest Income Expense
-65.50
-65.50
-212.38
-93.00
-72.00
Pretax Income
-3,477.64
-3,477.64
-2,900.68
-1,459.00
-1,230.00
Tax Provision
-71.64
-71.64
-64.82
-47.00
-56.00
Net Income Common Stockholders
-3,406.00
-3,406.00
-2,835.87
-1,412.00
-1,174.00
Diluted NI Available to Com Stockholders
-3,406.00
-3,406.00
-2,835.87
-1,412.00
-1,174.00
Basic EPS
-0.03
-0.03
-0.02
-0.01
-0.01
Diluted EPS
-0.03
-0.03
-0.02
-0.01
-0.01
Basic Average Shares
110,095.11
110,095.11
125,855.70
125,855.70
125,855.70
Diluted Average Shares
110,095.11
110,095.11
125,855.70
125,855.70
125,855.70
Total Operating Income as Reported
-2,648.82
-2,648.82
-2,688.30
-1,366.00
-1,158.00
Total Expenses
6,016.46
6,016.46
5,696.60
3,390.00
2,567.00
Net Income from Continuing & Discontinued Operation
-3,406.00
-3,406.00
-2,835.87
-1,412.00
-1,174.00
Normalized Income
-2,658.41
-2,658.41
-2,835.87
-1,412.00
-1,174.00
Interest Expense
65.50
65.50
212.38
93.00
72.00
Net Interest Income
-65.50
-65.50
-212.38
-93.00
-72.00
EBIT
-3,412.13
-3,412.13
-2,688.30
-1,366.00
-1,158.00
EBITDA
-3,185.81
-3,185.81
-2,636.62
-1,182.00
-955.00
Reconciled Cost of Revenue
2,229.86
2,229.86
2,229.11
1,525.00
945.00
Reconciled Depreciation
226.33
226.33
51.69
184.00
203.00
Net Income from Continuing Operation Net Minority Interest
-3,406.00
-3,406.00
-2,835.87
-1,412.00
-1,174.00
Total Unusual Items Excluding Goodwill
-763.32
-763.32
--
--
--
Total Unusual Items
-763.32
-763.32
--
--
--
Normalized EBITDA
-2,422.49
-2,422.49
-2,636.62
-1,182.00
-955.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-15.72
-15.72
--
--
--
12/31/2020 - 4/4/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NNH.ST New Nordic Healthbrands AB (publ)
16.10
+6.62%
CLBEY Calbee, Inc.
4.5600
0.00%
AGB2.DE AGRANA Beteiligungs-Aktiengesellschaft
10.80
+0.47%
APETIT.HE Apetit Oyj
13.80
-1.43%
BELL.SW Bell Food Group AG
259.00
-0.58%
BMK.L Benchmark Holdings plc
29.45
-0.17%
WLMIY Wilmar International Limited
22.49
+0.40%
AKBM.OL Aker BioMarine AS
65.10
+0.15%
ORON.SW ORIOR AG
38.50
-0.13%
GLB.L Glanbia plc
14.04
-0.07%